Evidence map›Paper›PMID 26474194›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2016

ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice.

Victoria Ulrich, Shari E Gelber, Milena Vukelic, Anastasia Sacharidou, Joachim Herz, Rolf T Urbanus, Philip G de Groot, David R Natale, Anirudha Harihara, Patricia Redecha and 4 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. B Cell Responses to the Placenta and Fetus.Annual review of pathology · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. The pathogenesis of obstetric APS: a 2023 update.Clinical immunology (Orlando, Fla.) · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Victoria UlrichCenter for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Shari E GelberDepartment of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York.
Milena VukelicDepartment of Medicine, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York.
Anastasia SacharidouCenter for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Joachim HerzDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas.
Rolf T UrbanusClinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, the Netherlands.
Philip G de GrootClinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, the Netherlands.
David R NataleDepartment of Reproductive Medicine, University of California-San Diego, San Diego, California.
Anirudha HariharaDepartment of Reproductive Medicine, University of California-San Diego, San Diego, California.
Patricia RedechaDepartment of Medicine, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York.
Vikki M AbrahamsDepartment of Obstetrics, Gynecology & Reproductive Sciences, Divisions of Reproductive Sciences and Maternal-Fetal Medicine, Yale School of Medicine, New Haven, Connecticut.
Philip W ShaulCenter for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Jane E Salmon *Department of Medicine, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York.
Chieko Mineo *Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
The University of Texas Southwestern Medical Center · USCornell University · USUniversity Medical Center Utrecht · NLUniversity of California, San Diego · USHospital for Special Surgery · USYale University · US

Funding

REPRODUCTIVE SCIENTIST TRAINING PROGRAMK12HD000849 · NICHD · WASHINGTON UNIVERSITY · PI Danny J Schust · 1988 to 2026
$33.2M
TRAINING PROGRAM IN LUNG BIOLOGY AND DISEASET32HL098040 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAUL, PHILIP W, TERADA, LANCE S · 2009 to 2024
$4.6M
Metabolism of the VLDL receptor and ApoE receptor 2R37HL063762 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI HERZ, JOACHIM J · 2010 to 2019
$4.0M
Molecular Basis of Synaptic Suppression by ApoER01NS093382 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI HERZ, JOACHIM J · 2016 to 2020
$2.0M
Discovery of Novel Interventions of the Antiphospholipid SyndromeR01HL109604 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI MINEO, CHIEKO · 2011 to 2014
$1.6M
NHLBI NIH HHS 5-R01-HL-109604NHLBI NIH HHS R01 HL109604NHLBI NIH HHS R37 HL063762NHLBI NIH HHS R37-HL-63762NHLBI NIH HHS T32 HL098040NICHD NIH HHS K12 HD000849NICHD NIH HHS K12-HD-000849NINDS NIH HHS R01 NS093382
6 · The paper itself

Abstract

objectivePregnancies in women with the antiphospholipid syndrome (APS) are frequently complicated by fetal loss and intrauterine growth restriction (IUGR). How circulating antiphospholipid antibodies (aPL) cause pregnancy complications in APS is poorly understood. We sought to determine whether the low-density lipoprotein receptor family member apolipoprotein E receptor 2 (ApoER2) mediates trophoblast dysfunction and pregnancy complications induced by aPL.

methodsPlacental and trophoblast ApoER2 expression was evaluated by immunohistochemistry and immunoblotting. Normal human IgG and aPL were purified from healthy individuals and APS patients, respectively. The role of ApoER2 in aPL-induced changes in trophoblast proliferation and migration and in kinase activation was assessed using RNA interference in HTR-8/SVneo cells. The participation of ApoER2 in aPL-induced pregnancy loss and IUGR was evaluated in pregnant ApoER2(+/+) and ApoER2(-/-) mice injected with aPL or normal human IgG.

resultsWe found that ApoER2 is abundant in human and mouse placental trophoblasts and in multiple trophoblast-derived cell lines, including HTR-8/SVneo cells. ApoER2 and its interaction with the cell surface protein β2 -glycoprotein I were required for aPL-induced inhibition of cultured trophoblast proliferation and migration. In parallel, aPL antagonism of Akt kinase activation by epidermal growth factor in trophoblasts was mediated by ApoER2. Furthermore, in a murine passive-transfer model of pregnancy complications of APS, ApoER2(-/-) mice were protected from both aPL-induced fetal loss and aPL-induced IUGR.

conclusionApoER2 plays a major role in the attenuation of trophoblast function by aPL, and the receptor mediates aPL-induced pregnancy complications in vivo in mice. ApoER2-directed interventions can now potentially be developed to combat the pregnancy complications associated with APS.

Indexed as

Abortion, SpontaneousAnimalsAntiphospholipid Syndromebeta 2-Glycoprotein ICell LineFemaleHumansImmunoblottingImmunohistochemistryKeratin-7LDL-Receptor Related ProteinsMicePlacentaPregnancyPregnancy ComplicationsRNA Interferencebeta 2-Glycoprotein IKeratin-7LDL-Receptor Related Proteinslow density lipoprotein receptor-related protein 8

Identifiers

PMID26474194
PMCPMC4767551
OpenAlexW2152081807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.